Comments
Loading...
BioCryst Pharma (BCRX) Forecast
NewsEarningsBioCryst Pharma (BCRX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestBioCryst Pharma (NASDAQ:BCRX) Stock Quotes, Forecast and News Summary
BioCryst Pharma Stock (NASDAQ: BCRX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy BioCryst Pharma (BCRX) stock?
You can purchase shares of BioCryst Pharma (NASDAQ:BCRX) through any online brokerage.
Who are BioCryst Pharma (BCRX) competitors?
Other companies in BioCryst Pharma’s space includes: Arcutis Biotherapeutics (NASDAQ:ARQT), Day One Biopharmaceutical (NASDAQ:DAWN), Xencor (NASDAQ:XNCR), Mesoblast (NASDAQ:MESO) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).
What is the forecast, or price target, for BioCryst Pharma (BCRX) stock?
BioCryst Pharma has a consensus price target of $13.22.
What is the current price for BioCryst Pharma (BCRX)?
The stock price for BioCryst Pharma (NASDAQ: BCRX) is $7.435 last updated December 18, 2024 at 12:31 PM EST.
Does BioCryst Pharma (BCRX) pay a dividend?
There are no upcoming dividends for BioCryst Pharma.
When is BioCryst Pharma (NASDAQ:BCRX) reporting earnings?
BioCryst Pharma’s Q4 earnings are confirmed for Monday, February 24, 2025.
Is BioCryst Pharma (BCRX) going to split?
There is no upcoming split for BioCryst Pharma.
What sector and industry does BioCryst Pharma (BCRX) operate in?
BioCryst Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.